Talphera - Forum WKN: A3DWPN ISIN: US00444T2096 Kürzel: TLPH Forum: Aktien User: Summer.76

AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update https://www.acelrx.com/news-releases/news-release-details/acelrx-pharmaceuticals-reports-first-quarter-2023-financial Request for Emergency Use Authorization of Niyad™ submitted to the FDA in April Divestment of DSUVIA® to Alora Pharmaceuticals closed April 3, 2023 $13.4 million in cash as of March 31, 2023 ...

https://www.acelrx.com/news-releases/news-release-details/acelrx-pharmaceuticals-announces-closing-divestment-dsuviar

https://seekingalpha.com/news/3952853-acelrx-pharmaceuticals-gaap-eps-of-1_00-beats-1_51-revenue-of-0_25m-misses-4_25m • AcelRx Pharmaceuticals press release (NASDAQ:ACRX): Q4 GAAP EPS of $1.00 beats by $1.51. • Revenue of $0.25M (+1150.0% Y/Y) misses by $4.25M. • Divestment of DSUVIA to Alora Pharmaceuticals expected to close the week of April 3, 2023

https://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-reports-full-year-and-fourth-quarter-2022-financial-results-and-provides-corporate-update-301786311.html AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update

Schreib ich ab den Laden... Fehlinvest. Klang so gut.

Der link dazu: https://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-announces-divestment-of-dsuvia-to-alora-pharmaceuticals-301771123.html

AcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora Pharmaceuticals up to $116.5 million in potential sales-based milestone payments

👀

AcelRx Announces $7.5 Million Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock https://www.prnewswire.com/news-releases/acelrx-announces-7-5-million-registered-direct-offering-of-common-stock-and-warrants-to-purchase-common-stock-301710152.html

Ist sie vom handel ausgesetzt?

Welches potential steckt hier drin? Das kursziel eines einsamen analysten scheint mir etwas fern ab. Aber gute news sollten bei der aktienzahl schon was auslösen. Was meint ihr?

Was hier los🤣

AcelRx Pharmaceuticals Announces European Peer-Reviewed Publication Supporting the Benefits of Sublingual Sufentanil Tablets For Post-Operative Pain Management in the Journal of Clinical Medicine https://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-announces-european-peer-reviewed-publication-supporting-the-benefits-of-sublingual-sufentanil-tablets-for-post-operative-pain-management-in-the-journal-of-clinical-medicine-301698026.html Patients reported lower pain scores, required fewer rescue doses and had a shorter hospital stay than patients receiving continuous femoral nerve block This study of patients following knee replacement surgery adds to a growing database supporting the benefits of using sufentanil sublingual tablets for surgical pain management ...

https://www.marketscreener.com/quote/stock/ACELRX-PHARMACEUTICALS-I-7314079/news/ACELRX-PHARMACEUTICALS-INC-Termination-of-a-Material-Definitive-Agreement-form-8-K-42481562/

Hoffentlich 😁

Klingt vielversprechend, aber auf die Umsetzung wird es ankommen. Die Studie wird hoffentlich ihren Teil dazu beitragen.